Sucralfate is the generic version of Carafate, a brand-name medicine. It's a prescription medication that's used to treat upper gastrointestinal ulcers, peptic ulcer disease, and ulcer recurrence. Sucralfate is a local mucosal adherent that is made up of the hydroxy aluminium salt of sucrose octasulfate. It develops a covering over ulcers by adhering to the damaged area, protecting it from acid and enzymes and speeding up the healing process.
Sucralfate is also used to treat ulcers and upper gastrointestinal disorders in dogs, horses, and cats that are caused by drugs (especially nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids), toxic chemical ingestion, liver disease, renal failure, carcinoma, stress (trauma, shock, sepsis, and burns), and inflammatory bowel disease.
Read More:
https://bloggerstrive.blogspot.com/2022/03/sucralfate-market-analysis-market.html
Click here for Sucralfate Market Report:
https://www.coherentmarketinsights.com/market-insight/sucralfate-market-2325
